Risk factors
Drugs Made In America Acquisition (DMAA) risk factors
Item 1A of every Drugs Made In America Acquisition Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors80 risks25 new10 dropped34 reworded
The company completed its initial public offering, raising capital and investing cash into a trust account.
Filed Apr 15, 2026 - FY2024 10-K risk factors65 risks
The company completed its initial public offering on January 29, 2025, raising gross proceeds of $200,000,000.
Filed Mar 31, 2025